SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 28 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $801,152,000 | +47.6% | 216,077,000 | -1.5% | 6.66% | +20.3% |
Q4 2014 | $542,741,000 | -26.4% | 219,440,000 | 0.0% | 5.54% | -40.3% |
Q3 2014 | $737,019,000 | +25.8% | 219,440,000 | 0.0% | 9.28% | +29.3% |
Q2 2014 | $585,836,000 | +19.1% | 219,440,000 | 0.0% | 7.18% | +14.8% |
Q1 2014 | $491,957,000 | +13.9% | 219,440,000 | 0.0% | 6.25% | +2.8% |
Q4 2013 | $431,748,000 | +28.8% | 219,440,000 | 0.0% | 6.08% | +27.7% |
Q3 2013 | $335,332,000 | +0.4% | 219,440,000 | 0.0% | 4.77% | -27.9% |
Q2 2013 | $334,029,000 | – | 219,440,000 | – | 6.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 219,440,000 | $585,836,000 | 7.18% |
SYMPHONY ASSET MANAGEMENT LLC | 11,727,000 | $31,333,000 | 3.26% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 28,200,000 | $75,347,000 | 0.92% |
WOLVERINE ASSET MANAGEMENT LLC | 11,943,000 | $31,896,000 | 0.70% |
DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $1,606,000 | 0.62% |
BNP PARIBAS FINANCIAL MARKETS | 1,200,000 | $320,628,000,000 | 0.30% |
CAPSTONE INVESTMENT ADVISORS, LLC | 3,000,000 | $7,998,000 | 0.10% |
Visium Asset Management, LP | 2,000,000 | $5,335,000 | 0.08% |
SG Americas Securities, LLC | 22,800 | $6,103,000 | 0.04% |
LORD, ABBETT & CO. LLC | 10,988,000 | $29,414,000 | 0.03% |